BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12017328)

  • 1. Assessment of nodal involvement and survival analysis in breast cancer patients using image cytometric data: statistical, neural network and fuzzy approaches.
    Seker H; Odetayo MO; Petrovic D; Naguib RN; Bartoli C; Alasio L; Lakshmi MS; Sherbet GV
    Anticancer Res; 2002; 22(1A):433-8. PubMed ID: 12017328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of nodal metastasis and prognosis in breast cancer: a neural model.
    Naguib RN; Adams AE; Horne CH; Angus B; Smith AF; Sherbet GV; Lennard TW
    Anticancer Res; 1997; 17(4A):2735-41. PubMed ID: 9252707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of image cytometry data of fine needle aspirated cells of breast cancer patients: a comparison between logistic regression and artificial neural networks.
    Mat-Sakim HA; Naguib RN; Lakshmi MS; Wadehra V; Lennard TW; Bhatavdekar J; Sherbet GV
    Anticancer Res; 1998; 18(4A):2723-6. PubMed ID: 9703935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
    Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
    Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
    Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
    Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
    Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T
    Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis.
    Chen SL; Hoehne FM; Giuliano AE
    Ann Surg Oncol; 2007 Dec; 14(12):3378-84. PubMed ID: 17899293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic accuracy of an artificial neural network in patients undergoing radical cystectomy for bladder cancer: a comparison with logistic regression analysis.
    Bassi P; Sacco E; De Marco V; Aragona M; Volpe A
    BJU Int; 2007 May; 99(5):1007-12. PubMed ID: 17437435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved prognostic index of axillary node involvement in breast cancer incorporating DNA ploidy and tumour size.
    Eskelinen M; Collan Y; Pajarinen P; Pesonen E; Kettunen K; Nordling S
    Acta Chir Scand; 1990 Aug; 156(8):521-7. PubMed ID: 2239052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ratios of involved nodes in early breast cancer.
    Vinh-Hung V; Verschraegen C; Promish DI; Cserni G; Van de Steene J; Tai P; Vlastos G; Voordeckers M; Storme G; Royce M
    Breast Cancer Res; 2004; 6(6):R680-8. PubMed ID: 15535850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lymph node ratio as prognostic factor in node-positive breast cancer.
    Voordeckers M; Vinh-Hung V; Van de Steene J; Lamote J; Storme G
    Radiother Oncol; 2004 Mar; 70(3):225-30. PubMed ID: 15064006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic markers in node-negative breast cancer: a prospective study.
    Kute TE; Russell GB; Zbieranski N; Long R; Johnston S; Williams H; Stackhouse C; Wilkins L; Evans I; Berry P; Rimmer K; Tucker E
    Cytometry B Clin Cytom; 2004 May; 59(1):24-31. PubMed ID: 15108167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prognostic model that makes quantitative estimates of probability of relapse for breast cancer patients.
    De Laurentiis M; De Placido S; Bianco AR; Clark GM; Ravdin PM
    Clin Cancer Res; 1999 Dec; 5(12):4133-9. PubMed ID: 10632351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fuzzy logic based-method for prognostic decision making in breast and prostate cancers.
    Seker H; Odetayo MO; Petrovic D; Naguib RN
    IEEE Trans Inf Technol Biomed; 2003 Jun; 7(2):114-22. PubMed ID: 12834167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.
    Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G
    Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Node-related factors and survival in node-positive breast carcinomas.
    Sivridis E; Giatromanolaki A; Galazios G; Koukourakis MI
    Breast; 2006 Jun; 15(3):382-9. PubMed ID: 16135406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.